Can Buying Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) Still Be Worthwhile?

Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) does about 1.59M shares in volume on a normal day but saw 2891361 shares change hands in the recent trading day. The company now has a market cap of 50.42M USD. Its current market price is $0.20, marking a decrease of -4.37% compared to the previous close of $0.21. The […]

Adaptimmune Therapeutics Plc ADR (ADAP): Investing In A Time Of Crisis

Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) currently has a daily average trading volume of 1.62M but it saw 1874018 shares traded in last market. With a market cap of 56.31M USD, the company’s current market price of $0.22 came falling about -4.37 while comparing to the previous closing price of $0.23. In past 52 weeks, the […]

Estimating Price Trends For Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP)

Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) does about 1.60M shares in volume on a normal day but saw 2890366 shares change hands in the recent trading day. The company now has a market cap of 70.83M USD. Its current market price is $0.28, marking a decrease of -4.81% compared to the previous close of $0.29. The […]

Adaptimmune Therapeutics Plc ADR (ADAP): Investing In A Time Of Crisis

Adaptimmune Therapeutics Plc ADR (NASDAQ:ADAP) currently has a daily average trading volume of 1.36M but it saw 13937167 shares traded in last market. With a market cap of 71.65M USD, the company’s current market price of $0.28 came falling about -37.65 while comparing to the previous closing price of $0.45. In past 52 weeks, the […]